Keyphrases
Antibody Titer
20%
Anticoagulation
20%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
100%
CD20+
20%
Chest CT
20%
Convalescent Plasma
20%
COVID-19
100%
COVID-19 Antibody
20%
COVID-19 Virus
100%
Cytarabine
40%
Dasatinib
40%
Ground-glass Opacity
20%
High-flow Nasal Cannula
20%
Immunosuppressive Therapy
20%
Inflammatory Markers
20%
Intensive Care Unit
20%
Leukemia
20%
Leukemia Therapy
20%
Lowercase
20%
Lymphocytes
20%
Lymphopenia
20%
Nasal
40%
New York City
20%
Polymerase Chain Reaction
60%
Recovered COVID-19 Patients
20%
Reinfection
20%
Rituximab
40%
Second Infection
20%
Severe COVID-19
100%
Severe COVID-19 Pneumonia
20%
Stable Conditions
20%
Viral Reactivation
20%
Virus Reactivation
100%
Young Female
20%
Medicine and Dentistry
Acute B-Cell Lymphoblastic Leukemia
100%
Anticoagulation
20%
CD20
20%
COVID-19
100%
Cytarabine
40%
Dasatinib
40%
Ground Glass Opacity
20%
Immunosuppressive Treatment
20%
Infection
20%
Intensive Care Unit
20%
Leukemia
40%
Lymphocyte
20%
Lymphocytopenia
20%
Nasal Cannula
20%
Polymerase Chain Reaction
60%
Reinfection
20%
Rituximab
40%
Severe Acute Respiratory Syndrome Coronavirus 2
80%
Virus Reactivation
100%